BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5731884)

  • 1. [On the problem of the therapeutical axis symptom of neuroleptic medicaments].
    Glatzel J
    Psychiatr Neurol Med Psychol (Leipz); 1968 Aug; 20(8):286-95. PubMed ID: 5731884
    [No Abstract]   [Full Text] [Related]  

  • 2. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psuedotetanus caused by neuroleptics. Description of a case caused by fluphenazine].
    Benevolo A
    Arch Ital Pediatr Pueric; 1966; 24(5):468-72. PubMed ID: 5991322
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-acting, antipsychotic agents and extrapyramidal side effects.
    Simpson GM
    Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled comparative study of fluphenazine and fluphenazine enanthate in acute and chronic psychotic patients.
    van Praag HM; Breetveld J; van Mesdag-Etty H; Westerhuis R; Pen A; Schut T
    Psychiatr Neurol Neurochir; 1970; 73(3):165-75. PubMed ID: 4912332
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and biological effects of fluphénazine décanoate. 35 cases].
    Borenstein P; Dumaine A; Cujo P
    Ann Med Psychol (Paris); 1970 Jul; 2(2):267-73. PubMed ID: 5475413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P; Lapresle J; Chain F
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of haloperidol in the treatment of extrapyramidal compulsive movement].
    Kivalo E; Weckman N
    Nervenarzt; 1970 Nov; 41(11):567-9. PubMed ID: 4249744
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting phenothiazine (fluphenazine decanoate) treatment of psychosis.
    Keskiner A; Simeon J; Fink M; Itil TM
    Arch Gen Psychiatry; 1968 Apr; 18(4):477-81. PubMed ID: 4868796
    [No Abstract]   [Full Text] [Related]  

  • 13. Adequate individualized dosages (AID) in perspective.
    Maerz JC
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):35-9. PubMed ID: 1019145
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy of haloperidol in chronic psychotic patients.
    Lapolla A
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 16. Greater than recommended drug dosages--some effects.
    Kline NS
    Am J Psychiatry; 1970 Jun; 126(12):1799. PubMed ID: 5441737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
    van Praag HM; Dols LC
    Am J Psychiatry; 1973 Jul; 130(7):801-4. PubMed ID: 4576449
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A; Ciurezu T; Cucu I
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children.
    Engelhardt DM; Polizos P; Waizer J; Hoffman SP
    J Autism Child Schizophr; 1973; 3(2):128-37. PubMed ID: 4583792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.